
The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) are investigating 19 cases of botched Botox reported across nine states in the United States.
Officials said that all the incidents involved women who either reported sick following the administration of counterfeit Botox injections of AbbVie or those who received injections from unlicensed or untrained individuals in non-healthcare environments.